Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Blood Reviews
|
December 1, 2024
Bispecific antibodies for the treatment of hematologic malignancies: The magic is T-cell redirection
Geoffrey Shouse
Current Opinion in Oncology
|
August 8, 2023
Update on bi-specific monoclonal antibodies for blood cancers
Geoffrey Shouse
Case Reports in Hematology
|
May 5, 2018
A Case Report of Nongerminal Center B-Cell Type Diffuse Large B-Cell Lymphoma Treated to Complete Response with Rituximab and Ibrutinib
Geoffrey Shouse, Miemie Thinn
Current Hematologic Malignancy Reports
|
November 20, 2019
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders
Geoffrey Shouse, Liana Nikolaenko
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 15, 2021
Advances in Immunotherapy for Diffuse Large B Cell Lymphoma
Geoffrey Shouse, Alex F Herrera
Cancer Treatment and Research
|
October 9, 2021
Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Acute Lymphoblastic Leukemia (B-ALL)
Geoffrey Shouse, Elizabeth Budde, Stephen Forman
Current Oncology Reports
|
April 14, 2022
CAR T-Cell Therapy in the Older Person: Indications and Risks
Geoffrey Shouse, Alexey V Danilov, Andy Artz
Current Opinion in Oncology
|
July 20, 2022
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers
Geoffrey Shouse, Olga V Danilova, Alexey V Danilov
Blood Reviews
|
May 12, 2023
Thinking "outside the germinal center": Re-educating T cells to combat follicular lymphoma
Swetha Kambhampati Thiruvengadam, Geoffrey Shouse, Alexey V Danilov
Oncotarget
|
August 18, 2016
Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest
Geoffrey Shouse, Rosalia de Necochea-Campion, Saied Mirshahidi, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Blood Reviews
|
December 1, 2024
Bispecific antibodies for the treatment of hematologic malignancies: The magic is T-cell redirection
Geoffrey Shouse
Current Opinion in Oncology
|
August 8, 2023
Update on bi-specific monoclonal antibodies for blood cancers
Geoffrey Shouse
Case Reports in Hematology
|
May 5, 2018
A Case Report of Nongerminal Center B-Cell Type Diffuse Large B-Cell Lymphoma Treated to Complete Response with Rituximab and Ibrutinib
Geoffrey Shouse, Miemie Thinn
Current Hematologic Malignancy Reports
|
November 20, 2019
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders
Geoffrey Shouse, Liana Nikolaenko
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 15, 2021
Advances in Immunotherapy for Diffuse Large B Cell Lymphoma
Geoffrey Shouse, Alex F Herrera
Cancer Treatment and Research
|
October 9, 2021
Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Acute Lymphoblastic Leukemia (B-ALL)
Geoffrey Shouse, Elizabeth Budde, Stephen Forman
Current Oncology Reports
|
April 14, 2022
CAR T-Cell Therapy in the Older Person: Indications and Risks
Geoffrey Shouse, Alexey V Danilov, Andy Artz
Current Opinion in Oncology
|
July 20, 2022
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers
Geoffrey Shouse, Olga V Danilova, Alexey V Danilov
Blood Reviews
|
May 12, 2023
Thinking "outside the germinal center": Re-educating T cells to combat follicular lymphoma
Swetha Kambhampati Thiruvengadam, Geoffrey Shouse, Alexey V Danilov
Oncotarget
|
August 18, 2016
Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest
Geoffrey Shouse, Rosalia de Necochea-Campion, Saied Mirshahidi, et al.
Page
of 6